SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-12-000060
Filing Date
2012-11-14
Accepted
2012-11-14 14:05:56
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-2012930x10q.htm 10-Q 1093349
2 EXHIBIT 31.1 lgnd-ex311_2012930xq3.htm EX-31.1 13643
3 EXHIBIT 31.2 lgnd-ex312_2012930xq3.htm EX-31.2 13619
4 EXHIBIT 32.1 lgnd-ex321_2012930xq3.htm EX-32.1 7957
5 EXHIBIT 32.2 lgnd-ex322_2012930xq3.htm EX-32.2 7755
  Complete submission text file 0000886163-12-000060.txt   9943469

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lgnd-20120930.xml EX-101.INS 1815303
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20120930.xsd EX-101.SCH 57443
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20120930_cal.xml EX-101.CAL 79919
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20120930_def.xml EX-101.DEF 222318
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20120930_lab.xml EX-101.LAB 789207
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20120930_pre.xml EX-101.PRE 406012
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 121203128
SIC: 2834 Pharmaceutical Preparations